The Signal Journal
Back

Tag

bayer

Judge Rejects Bayer Bid to Block J&J Erleada Ads

Judge Dale Ho in Manhattan denied Bayer's request to block Johnson & Johnson's advertising claiming Erleada cuts prostate cancer mortality risk by 51%, finding Bayer unlikely to prevail on its false advertising claims. The ruling leaves J&J's marketing campaign intact while the underlying lawsuit continues. Nubeqa and

AWS Launches Amazon Bio Discovery for AI Drug Design

AWS launched Amazon Bio Discovery, an AI platform enabling researchers to design and evaluate drug molecules without writing code. The service integrates biological foundation models, lab partner routing, and automated result feedback, compressing months of early-stage work into weeks. Bayer, the Broad Institute, and V

← Back

Tag

bayer

Amazon Enters Drug Discovery Race with AI Platform for Faster Molecule Design

AWS launched Amazon Bio Discovery, an AI platform enabling researchers to design and evaluate drug molecules without writing code. The service integrates biological foundation models, lab partner routing, and automated result feedback, compressing months of early-stage work into weeks. Bayer, the Broad Institute, and V

2mo ago · 1 min · Technology

— End of feed —